Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-02-02

Clinical Trial Update: Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating naratriptan for post-traumatic headache associated with cognitive dysfunction was terminated, with results posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naratriptan (Naratriptan)

Snippet

Sponsor: Cady, Roger, M.D. | Conditions: Post Traumatic Headache | Phase 4 | Status: TERMINATED | Results posted: 2010-02-02